Pediatrics Doctors in Oxford, GA Accepting Medicare
1 Pediatrics doctors found. Showing 1 - 1
 Mrs. Lynda Frankena Reagan, P.T. Pediatrics - Neurodevelopmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 190 Bostwick Rd, Oxford, GA 30054 Phone: 770-784-1893 Fax: 770-784-1893 |
News Archive
Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that additional results from its Phase 3 trial (SYMMETRYSM) of elesclomol in combination with paclitaxel in metastatic melanoma was presented at the Perspectives in Melanoma XIII Conference by Steven O'Day, M.D., principal investigator and Chief of Research and Director of the Melanoma Program at the Angeles Clinic in Santa Monica, California.
Obstructive sleep apnea leads to poorer prognosis after stroke
Stroke victims tend to do worse if they also have diagnosed or undiagnosed obstructive sleep apnea prior to having the stroke, according to a study presented April 28, 2009, at the American Academy of Neurology (AAN) annual meeting in Seattle.
New study provides important insights on mosquitoes that spread disease
The Asian tiger mosquito (Aedes albopictus) is a highly invasive species and a vector of multiple pathogens including various viruses, such as chikungunya, dengue, and Zika.
Radio Frequency Ablation emerges as an alternative treatment for inoperable liver cancer
Hollywood talent manager Louis Bershad, 68, whose clients include many top actors in town, recently underwent a routine MRI for kidney stones only to learn from his urologist that he also had a tumor in his left kidney.
Study findings underscore importance of PD-1/PD-L1 expression in oncogenic signaling pathways
Caris Life Sciences® today announced the presentation of data from two studies in which researchers utilized Caris Molecular Intelligence®, the company's panomic, comprehensive tumor profiling service, to identify potential therapeutic targets in patients with colorectal and pancreatic cancer subtypes, based on expression of the programmed cell death protein 1 (PD-1) and its ligand, PD-L1.
› Verified 9 days ago